Blog Post

CFTR Modulator Therapies

Here’s what you need to know about the three CFTR (cystic fibrosis transmembrane conductance regulator) modulators, ivacaftor (Kalydeco®), lumacaftor/ivacaftor (Orkambi®), and tezacaftor/ivacaftor (Symdeko™).

Learn More

Did You Know?

Approximately 1,000 new cases of cystic fibrosis are diagnosed each year.

Share with friends

Resource

2016 Cystic Fibrosis Foundation Patient Registry Highlights

Highlights from the 2016 Cystic Fibrosis Foundation Patient Registry data include improvements in life expectancy and other aspects of living with cystic fibrosis, and reflect the collective efforts of the CF community to help more people with CF reach key life milestones.


Learn More

Blog Post

Find Out What Therapies We Are Researching for People With Rare and Nonsense Mutations

Although 90-95 percent of people with cystic fibrosis are expected to benefit from CF transmembrane regulator (CFTR) modulators, 5 percent of the population will still need alternative therapies to address the underlying cause of their disease. Learn more about the research that the Cystic Fibrosis Foundation is doing to find treatments for the 5 percent of people with these rare and nonsense mutations.

Learn More

Blog Post

Sign Up for Advocacy Action Alerts

Want to learn more about CF advocacy? Sign up to receive our emails and action alerts.

Learn More

Call us at 1 (800) FIGHT CF

or: 1 (800)-344-4823

Have a question? We can help!

Find a care center near you